Century Therapeutics Files 8-K

Ticker: IPSC · Form: 8-K · Filed: Apr 11, 2024 · CIK: 1850119

Century Therapeutics, INC. 8-K Filing Summary
FieldDetail
CompanyCentury Therapeutics, INC. (IPSC)
Form Type8-K
Filed DateApr 11, 2024
Risk Levellow
Pages2
Reading Time2 min
Key Dollar Amounts$0.0001
Sentimentneutral

Sentiment: neutral

Topics: financial-reporting, exhibits

TL;DR

Century Therapeutics filed an 8-K, mostly for financial docs, no big news.

AI Summary

On April 11, 2024, Century Therapeutics, Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, with no specific material events or other significant business updates detailed in the provided text. The company is incorporated in Delaware and headquartered in Philadelphia, PA.

Why It Matters

This 8-K filing indicates routine financial reporting and exhibit submissions by Century Therapeutics, Inc. without disclosing new material events.

Risk Assessment

Risk Level: low — The filing is a routine 8-K for financial statements and exhibits, not indicating any immediate material changes or risks.

Key Numbers

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing?

The primary purpose of this 8-K filing is to report financial statements and exhibits, as indicated by the 'ITEM INFORMATION: Financial Statements and Exhibits' section.

When was this 8-K report filed?

This 8-K report was filed on April 11, 2024.

What is Century Therapeutics, Inc.'s state of incorporation?

Century Therapeutics, Inc. is incorporated in Delaware.

Where are Century Therapeutics, Inc.'s principal executive offices located?

Century Therapeutics, Inc.'s principal executive offices are located at 25 North 38th Street, 11th Floor, Philadelphia, Pennsylvania, 19104.

Does this filing report any specific material events?

Based on the provided text, this filing is categorized under 'Other Events' and 'Financial Statements and Exhibits,' and does not explicitly detail any specific new material events.

Filing Stats: 456 words · 2 min read · ~2 pages · Grade level 10.9 · Accepted 2024-04-11 14:42:28

Key Financial Figures

Filing Documents

01

Item 8.01 Other Events On April 11, 2024, Century Therapeutics, Inc. (the "Company") updated information reflected in a slide presentation, which is attached hereto as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. Representatives of the Company will use the updated presentation in various meetings with investors from time to time.

Financial Statements and Exhibits

Financial Statements and Exhibits (d) Exhibits Exhibit No. Document 99.1 Investor Presentation of Century Therapeutics, Inc., dated April 11, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. CENTURY THERAPEUTICS, INC. By: /s/ Brent Pfeiffenberger, Pharm.D. Name: Brent Pfeiffenberger, Pharm.D. Title: President and Chief Executive Officer Date: April 11, 2024

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing